ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA

  1. Charlotte Lässig
  2. Sarah Matheisl
  3. Konstantin MJ Sparrer
  4. Carina C de Oliveira Mann
  5. Manuela Moldt
  6. Jenish R Patel
  7. Marion Goldeck
  8. Gunther Hartmann
  9. Adolfo García-Sastre
  10. Veit Hornung
  11. Karl‐Klaus Conzelmann
  12. Roland Beckmann
  13. Karl-Peter Hopfner  Is a corresponding author
  1. Ludwig Maximilian University of Munich, Germany
  2. Harvard Medical School, United States
  3. Icahn School of Medicine at Mount Sinai, United States
  4. University of Bonn, Germany

Abstract

The cytosolic antiviral innate immune sensor RIG-I distinguishes 5′ tri- or diphosphate containing viral double-stranded (ds) RNA from self-RNA by an incompletely understood mechanism that involves ATP hydrolysis by RIG-I's RNA translocase domain. Recently discovered mutations in ATPase motifs can lead to the multi-system disorder Singleton-Merten Syndrome (SMS) and increased interferon levels, suggesting misregulated signaling by RIG-I. Here we report that SMS mutations phenocopy a mutation that allows ATP binding but prevents hydrolysis. ATPase deficient RIG-I constitutively signals through endogenous RNA and co-purifies with self-RNA even from virus infected cells. Biochemical studies and cryo-electron microscopy identify a 60S ribosomal expansion segment as a dominant self-RNA that is stably bound by ATPase deficient RIG-I. ATP hydrolysis displaces wild-type RIG-I from this self-RNA but not from 5' triphosphate dsRNA. Our results indicate that ATP-hydrolysis prevents recognition of self-RNA and suggest that SMS mutations lead to unintentional signaling through prolonged RNA binding.

Article and author information

Author details

  1. Charlotte Lässig

    Gene Center, Department of Biochemistry, Ludwig Maximilian University of Munich, Munich, Germany
    Competing interests
    No competing interests declared.
  2. Sarah Matheisl

    Gene Center, Department of Biochemistry, Ludwig Maximilian University of Munich, Munich, Germany
    Competing interests
    No competing interests declared.
  3. Konstantin MJ Sparrer

    Department of Microbiology and Immunobiology, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  4. Carina C de Oliveira Mann

    Gene Center, Department of Biochemistry, Ludwig Maximilian University of Munich, Munich, Germany
    Competing interests
    No competing interests declared.
  5. Manuela Moldt

    Gene Center, Department of Biochemistry, Ludwig Maximilian University of Munich, Munich, Germany
    Competing interests
    No competing interests declared.
  6. Jenish R Patel

    Department of Microbiology, Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, United States
    Competing interests
    No competing interests declared.
  7. Marion Goldeck

    Institute for Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, University of Bonn, Bonn, Germany
    Competing interests
    No competing interests declared.
  8. Gunther Hartmann

    Institute for Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, University of Bonn, Bonn, Germany
    Competing interests
    Gunther Hartmann, co-founder and shareholder of the Rigontec GmbH.
  9. Adolfo García-Sastre

    Department of Microbiology, Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, United States
    Competing interests
    No competing interests declared.
  10. Veit Hornung

    Institute of Molecular Medicine, University Hospital Bonn, University of Bonn, Bonn, Germany
    Competing interests
    Veit Hornung, co-founder and shareholder of the Rigontec GmbH.
  11. Karl‐Klaus Conzelmann

    Max von Pettenkofer-Institute, Gene Center, Ludwig Maximilian University of Munich, Munich, Germany
    Competing interests
    No competing interests declared.
  12. Roland Beckmann

    Gene Center, Department of Biochemistry, Ludwig Maximilian University of Munich, Munich, Germany
    Competing interests
    No competing interests declared.
  13. Karl-Peter Hopfner

    Gene Center, Department of Biochemistry, Ludwig Maximilian University of Munich, Munich, Germany
    For correspondence
    hopfner@genzentrum.lmu.de
    Competing interests
    No competing interests declared.

Copyright

© 2015, Lässig et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,047
    views
  • 1,133
    downloads
  • 74
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Charlotte Lässig
  2. Sarah Matheisl
  3. Konstantin MJ Sparrer
  4. Carina C de Oliveira Mann
  5. Manuela Moldt
  6. Jenish R Patel
  7. Marion Goldeck
  8. Gunther Hartmann
  9. Adolfo García-Sastre
  10. Veit Hornung
  11. Karl‐Klaus Conzelmann
  12. Roland Beckmann
  13. Karl-Peter Hopfner
(2015)
ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA
eLife 4:e10859.
https://doi.org/10.7554/eLife.10859

Share this article

https://doi.org/10.7554/eLife.10859

Further reading

    1. Biochemistry and Chemical Biology
    2. Immunology and Inflammation
    David C Rawling, Megan E Fitzgerald, Anna Marie Pyle
    Research Article Updated

    Retinoic acid-inducible gene I (RIG-I) initiates a rapid innate immune response upon detection and binding to viral ribonucleic acid (RNA). This signal activation occurs only when pathogenic RNA is identified, despite the ability of RIG-I to bind endogenous RNA while surveying the cytoplasm. Here we show that ATP binding and hydrolysis by RIG-I play a key role in the identification of viral targets and the activation of signaling. Using biochemical and cell-based assays together with mutagenesis, we show that ATP binding, and not hydrolysis, is required for RIG-I signaling on viral RNA. However, we show that ATP hydrolysis does provide an important function by recycling RIG-I and promoting its dissociation from non-pathogenic RNA. This activity provides a valuable proof-reading mechanism that enhances specificity and prevents an antiviral response upon encounter with host RNA molecules.